Your session is about to expire
← Back to Search
Behavioral Intervention
Impacto for Smoking Cessation
N/A
Waitlist Available
Research Sponsored by University of Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
1) 18 to 55 year of age, 2) current smoker (i.e., at least 6 cigarettes/day), 3) not currently engaged in smoking cessation treatment, 4), high anxiety sensitivity (AS) score defined as an ASI-III score of ≥ 23, 5) motivation to quit \> 5 on a 10 pt. scale, 6) Spanish speaking, and 7) currently own an Android-compatible mobile phone.
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 2, 4, 6, and 8
Awards & highlights
Summary
This trial will test a mobile app called Impacto, which is designed to help Spanish-speakers quit smoking.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ weeks 2, 4, 6, and 8
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 2, 4, 6, and 8
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
7-Day Point Prevalence Smoking Abstinence
Change in Smoking Rate (# cigarettes per day)
Secondary study objectives
Change in Anxiety Sensitivity
Change in Mood and Anxiety Symptoms
Daily Adherence to Use of Impacto Mobile App (Impacto Condition Only)
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ImpactoExperimental Treatment1 Intervention
This is the mobile app to be developed and evaluated in this project.
Group II: Dejar de Fumar AsistenteActive Control1 Intervention
This is the mobile app that will serve as the control condition in evaluating the efficacy of Impacto.
Find a Location
Who is running the clinical trial?
University of HoustonLead Sponsor
149 Previous Clinical Trials
47,834 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,543 Previous Clinical Trials
3,249,338 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger